iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN
JJS was delisted on the 7th of June, 2023.
2 hedge funds and large institutions have $4.23M invested in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
19% more capital invested
Capital invested by funds: $3.57M → $4.23M (+$665K)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $4.2M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $34K | -$1.4K | -29 | -4% |
|
JJS Hedge Fund Activity: Q2 2021 in Review
2 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) for Q2 2021, worth a combined $4.23M — up 19% from $3.57M a quarter earlier.
Fund positioning in JJS was balanced in Q2 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $1.4K.
- 2 institutional investors held iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN (JJS) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $4.23M of iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN stock for Q2 2021, up 19% quarter-over-quarter.
- 0 funds opened new iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN positions in Q2 2021 and 0 closed out.
- The largest iPath Series B Bloomberg Softs Subindex Total ReturnSM ETN seller in Q2 2021 was UBS Group, an estimated $1.4K sold.
Based on aggregated 13F filings for Q2 2021.